Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
AusPAR: Vaxneuvance
Australian Public Assessment Report
Device/Product Name
Vaxneuvance
Active ingredients
Pneumococcal 15-valent conjugate vaccine (CRM197 protein), adsorbed
AusPAR Date
Published
Submission Number
PM-2022-00382-1-2
Submission Type
Extension of indication
Decision
Approved